BioSpace News Archive

Bio-Rad Laboratories, Inc. announced financial results for the second quarter ended June 30, 2018.

Community Healthcare Trust Incorporated (NYSE: CHCT) (the “Company”) today announced results for the three months ended June 30, 2018.

RXi Pharmaceuticals Corporation announced that it will report its financial results for the second quarter ended June 30, 2018, and provide a business update on Tuesday, August 14, 2018 after the close of the U.S. financial markets.

Second-Quarter 2018 Financial Results

ProMis Neurosciences, Inc. (TSX: PMN; OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced it has issued a narrated commentary on key lessons from this year’s Alzheimer’s Association International Conference (AAIC).

Dr. Ekas and Dr. Watsky now join Rallybio’s co-founders and other veteran industry executives in advancing Rallybio’s mission to identify and accelerate the development of transformative breakthrough therapies for patients with severe and rare disorders.

Q2 2018 net income was $0.18 per basic and $0.17 per diluted share and adjusted non-GAAP net income of $0.99 per basic and $0.95 per diluted share

The Genomics 2.0 Summit is in Park City, Utah; Thursday, August 9, 2018 at 11:30 am.

Onconova Therapeutics, Inc. announced that the Company will release its second quarter 2018 financial results on August 14, 2018 before the market opens.

HEMLIBRA is the first new treatment in almost 20 years for this most severe form of hemophilia1 and the only medicine that is self-injected once weekly